RE:RE:Strategic Move at Oncolytics Problem is, companies do not normally offer a 2000% premium to the current trading range, which is basically what you'd need at this point to be even halfway fair to account for the work the company has done to bring this drug this far... We need to climb back up to the $5ish level before getting a healthy premium on that share price... Events over the next 6+ months should provide us that opportunity...